Tarpeyo and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Tarpeyo (budesonide), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Lisinopril, and have Iga nephropathy.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Tarpeyo. It is created by eHealthMe based on reports of 2,758 people who have side effects when taking Tarpeyo from the FDA, and is updated regularly.

What is Tarpeyo?

Tarpeyo has active ingredients of budesonide. eHealthMe is studying from 2,758 Tarpeyo users. Check the latest studies of Tarpeyo.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,953 drugs and 2,940 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

2,758 people reported to have side effects when taking Tarpeyo.
Among them, 18 people (0.65%) have Hyperkalemia.

Among these 18 people:

How long have people been on Tarpeyo when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Tarpeyo? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Hyperkalemia when taking Tarpeyo? *

What are other drugs people take besides Tarpeyo? *

What are other side effects people have besides Hyperkalemia? *

High Blood Pressure: 3 people, 16.67%
Renal Impairment (severely reduced kidney function): 3 people, 16.67%
Blood Glucose Increased: 2 people, 11.11%
Head Injury: 2 people, 11.11%
Headache (pain in head): 2 people, 11.11%
Weight Increased: 1 person, 5.56%
Carbon Dioxide Decreased: 1 person, 5.56%
Chronic Kidney Disease: 1 person, 5.56%
Energy Increased: 1 person, 5.56%
Fatigue (feeling of tiredness): 1 person, 5.56%

What are the existing conditions these people have? *

Iga Nephropathy (kidney disease- condition prevents the kidneys from filtering waste): 13 people, 72.22%
Haematuria (presence of blood in urine): 5 people, 27.78%
Chronic Kidney Disease: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tarpeyo and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tarpeyo:

Tarpeyo (2,758 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Tarpeyo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,953 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,940 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Tarpeyo) and Tarpeyo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.